EPISODE · Jul 7, 2025 · 12 MIN
ASCO 2025 Plenary - MATTERHORN
from Two Onc Docs
This week’s episode will be focusing on one of the GI plenary session abstracts presented at the ASCO Annual Meeting 2025, the MATTERHORN trial: phase 3 durvalumab + FLOT which is 5FU leucovorin, oxaliplatin and docetaxel in resectable gastric or GE junction CA.
Embed this episode
NOW PLAYING
ASCO 2025 Plenary - MATTERHORN
0:00
12:27
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Two Onc Docs?
This episode is 12 minutes long.
When was this Two Onc Docs episode published?
This episode was published on July 7, 2025.
Can I download this Two Onc Docs episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!